yahoo_financeOriginal article
Serina Completes Enrollment, Dosing in First Cohort of Phase 1b Trial in Parkinson's Disease
Phase 1Positive
AI Analysis
Summary
Serina has completed enrollment and dosing in the first cohort of its Phase 1b trial for Parkinson's Disease. This represents routine progress in early-stage clinical development.
Clinical Trial Data
Phase
1b
Outcome Details
Enrollment and dosing completed in first cohort
Importance:4/10
Sentiment:
0.30
Clinical TrialPhase 1bParkinson's DiseaseTrial Progress
Related Companies
Read the original article
Published by yahoo_finance on July 23, 2026 1:06 PM